Axiles Bionics key facts
as of Oct 2026- Developer of robotic prosthesis technology designed to improve the quality of life for people with amputations.
- Axiles Bionics is valued at approximately $34.5M as of Oct 2026 (last reported valuation).
- It has raised $11.7M; the latest was Later Stage VC ($8.4M) in Jun 2025.
- Notable investors include European Innovation Council, Finance&Invest.Brussels, European Innovation Council (Belgium), PE Group, RobotUnion — 7 tracked in total.
- Status: Privately Held (backing).
Axiles Bionics's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·Watch Axiles Bionics: the Monday email on marks, rounds and moves
Axiles Bionics funding rounds
No funding rounds for Axiles Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Axiles Bionics valuation
Axiles Bionics's last reported valuation was $34.5 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
Axiles Bionics investors
7 investors are on record for Axiles Bionics, including European Innovation Council, Finance&Invest.Brussels, European Innovation Council (Belgium) and PE Group.
About Axiles Bionics
Developer of robotic prosthesis technology designed to improve the quality of life for people with amputations. The company's prosthesis offers a unique combination of human ankle strength and flexibility, along with robotic features, enabling people with limb disorders to benefit from smart robotic ankle-foot prostheses that provide improved movement and support.
- Sector
- Healthcare
- HQ
- Brussels, Belgium
- Founded
- 2018
- Employees
- 23
- Website
- axilesbionics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.